Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $211.65 | Total: $1,058.25 |
| 1 | 10 | $179.28 | Total: $1,792.80 |
| 1 | 25 | $151.89 | Total: $3,797.25 |
| 1 | 50 | $129.48 | Total: $6,474.00 |
| 1 | 100 | $112.05 | Total: $11,205.00 |
Overview
Farglitazar (GI-262570) is a PPAR-? agonist and insulin sensitizer that inhibits stellate cell activation by activating receptor ? via oxidative enzymes proliferators and is used in the study of diabetes.
Chemical Properties
| Molecular Formula | C34H30N2O5 |
| Molecular Weight | 546.61 |
| CAS Numbers | 196808-45-4 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(=O)(C1=C(N[C@@H](CC2=CC=C(OCCC=3N=C(OC3C)C4=CC=CC=C4)C=C2)C(O)=O)C=CC=C1)C5=CC=CC=C5 |
Storage and Handling
0C Short Term, -20C Long Term
References
Reynolds DW, et al. The Degradation Chemistry of Farglitazar and Elucidation of the Oxidative Degradation Mechanisms. J Pharm Sci. 2017 Apr;106[4] 982-993.